Absci Corporation announced the appointment of Andreas Busch, PhD, to its Board of Directors. Dr. Busch is the former EVP and Chief Scientific Officer at Shire Plc and Head of Drug Discovery at Bayer and is currently Chief Scientific Officer at Cyclerion Therapeutics Inc. He brings over twenty years of pharmaceutical industry executive experience in drug discovery R&D leadership positions. Previously, Dr. Busch served as Executive Vice President, Head of Research & Development and Chief Scientific Officer at Shire Plc.

Prior to joining Shire, he held several senior leadership positions in his 13-year tenure at Bayer group, most recently as Executive Vice President and Head of Global Drug Discovery. Upon his appointment, Dr. Busch was also appointed to serve on the Nominating and Corporate Governance Committee of the Board.